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Background: Pharmacists are knowledgeable, accessible health care professionals who can provide services that
improve outcomes in mental health care. Various challenges and opportunities can exist in pharmacy practice to
hinder or support pharmacists’ efforts. We used a theory-informed approach to development and implementation
of a capacity-building program to enhance pharmacists’ roles in mental health care.
Methods: Theories and frameworks including the Consolidated Framework for Implementation Research, the
Theoretical Domains Framework, and the Behaviour Change Wheel were used to inform the conceptualization,
development, and implementation of a capacity-building program to enhance pharmacists’ roles in mental health care.
Results: The More Than Meds program was developed and implemented through an iterative process. The main
program components included: an education and training day; use of a train-the-trainer approach from partnerships with
pharmacists and people with lived experience of mental illness; development of a community of practice through email
communications, a website, and a newsletter; and use of educational outreach delivered by pharmacists. Theories and
frameworks used throughout the program’s development and implementation facilitated a means to conceptualize the
component parts of the program as well as its overall presence as a whole from inception through evolution in
implementation. Using theoretical foundations for the program enabled critical consideration and understanding of
issues related to trialability and adaptability of the program.
Conclusions: Theory was essential to the underlying development and implementation of a capacity-building program
for enhancing services by pharmacists for people with lived experience of mental illness. Lessons learned from the
development and implementation of this program are informing current research and evolution of the program.
Keywords: Community pharmacy, Mental illness, Behaviour Change Wheel, Consolidated Framework for Implementation
ResearchIntroduction
People with lived experience of mental illness have in-
equalities and inequities in mental health care service
access, delivery, and outcomes. A common strategy pro-
posed for improving service access, delivery, and health
outcomes includes utilizing the full complement and
skills set of various health care professionals in the care
of patients in community settings. This approach is in-
cluded in mental health strategies and other strategic
guidance. Through our program of research, we have
been examining new ways in which pharmacists can
support the bridging of gaps in the health system to* Correspondence: andrea.murphy@dal.ca
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unless otherwise stated.improve care and outcomes, increase access to health
information and services, and enhance patient system
navigation of mental health and addictions care.
Pharmacists are traditionally viewed as the medication
therapy experts. More recently, they have been recog-
nized for their knowledge and skills in assuming ad-
vanced roles and scopes of practice in community and
specialized clinical areas as well as in public health-
related initiatives. Existing literature demonstrates that
clinic and community practice-based pharmacists can
improve mental health-related outcomes [1-3]. These
outcomes go beyond mental health outcomes as phar-
macists support physical and mental wellbeing of their
patients while engaging in health promotion activities
and managing chronic health problems.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Canadian context are generally thought to be accessible in
both location and in terms of hours of operation. In Nova
Scotia, Canada, much of the population lives within walk-
ing distance or a short drive from a community pharmacy
[4], many of which are open on weekends, evenings, and
holidays and pharmacists in these locations can be
accessed in person or via telephone without the need
of an appointment. This accessibility is viewed as an
asset in rural and underserved areas and as well for
people living with mental illnesses in communities who
may require additional support.
In our program of research, one of our main goals is
to design programs and interventions that capitalize on
the knowledge, skills, and accessibility of pharmacists for
improving mental health outcomes in communities. This
requires pharmacists to engage in quality care activities
that are within their scope of practice, but extend be-
yond medication dispensing duties, including health sys-
tem navigation support and establishing robust linkages
with community-based support groups. For most phar-
macists, this would require a change in practice behav-
iour and role expectations. To support pharmacists in
these activities, we recognized that an intervention would
be needed to help with changing and facilitating behav-
iours. Numerous system, clinician, and patient factors
complicate conceptualizing and preparing for evidence-
informed practice change, implementing change, and
sustaining changes in health care. Before implementing
complex and typically expensive behaviour change inter-
ventions in practice, systematically conceptualizing the be-
haviours as they occur in context and the process of
implementation for interventions can provide invaluable
insights into variables that influence the process. Using
frameworks, models, and theories to understand behav-
iours in context and design interventions allows for de-
scription, characterization, and contextualization of as
many potential factors towards increasing success of
changing behaviours and ideally, allowing for potential
replication of interventions with adaptable implemen-
tation strategies in other settings. Based on this premise,
we aimed to design our capacity-building intervention for
improving community pharmacy-based mental health care
using theory and frameworks to guide our work.
Methods
Our process was iterative and fluid, moving between
frameworks that considered implementation of interven-
tions on a broad level to those that guided behaviour
change for individuals. Many theories and frameworks
are available to guide researchers in this area but we
chose those that resonated with the purpose of our
work. We selected a complementary set of implementa-
tion and behaviour change theories and frameworks toallow us to consider the effect of the implementation
process on the design of the intervention. Many con-
structs among theories and frameworks for individual
behaviour change and implementation have overlapping
characteristics or qualities and for our purposes, they are
not mutually exclusive. With our underlying philosophy
that intervention implementation and intervention de-
sign for behaviour change are inextricably linked, this
allowed us to consciously give priority to the process of
implementation within the design of the intervention.
As can be anticipated with using these frameworks or
theories, changing pharmacists’ behaviours in their care
of patients with lived experience of mental illness, at a
minimum, must consider not only the different pharma-
cists as individuals but the actions of these individuals
within different inner contexts that exist in larger orga-
nizations with a host of external contextual factors. The
strength and relative advantage of the intervention must
be recognized, along with its potential for adaptation to
the context prior to adoption must also be considered [5].
Our first exercise included a broad examination of fac-
tors influencing pharmacists in their practice settings to-
wards intervention development and any factors that
may influence the implementation of an intervention. In
our original conceptualization of an intervention, we re-
ferred to an implementation framework that we have
used in our program of research previously; the Promoting
Action on Research Implementation in Health Systems
(PARIHS) [6-11] framework, in which successful im-
plementation of evidence or interventions in health
care will depend on the facilitation of the intervention/
evidence, the context in which it is being implemented,
and the strength of the evidence/intervention. How-
ever, as implementation science literature and theory
continue to evolve, we found the meta-theory devel-
oped through the work of Damschroder and colleagues
[5] offered advantages for us in more comprehensively
conceptualizing the implementation of an intervention
in pharmacy practice. The Consolidated Framework
for Implementation Research (CFIR) (Figure 1), ex-
tends previous synthesis work of over 500 published
articles, and was developed with the intent to create
constructs for further testing and developing of theories
for explaining successes and failures in healthcare imple-
mentation. The CFIR includes an additional 18 models
from the published literature to create the “overarching
typology” including a list of constructs to help researchers
determine what works, where, and why across contexts
[5]. In our work, the CFIR provided a foundation for a
meta-view of understanding important variables to con-
sider with the implementation of a complex intervention
designed for changing behaviour vis-a-vis community
pharmacists in mental health care. The five major domains
of the CFIR include the intervention, individuals involved,
Figure 1 The Consolidated Framework for Implementation Research [5].
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texts) and outer (including social, economic, and political
contexts) settings, and the process by which implementa-
tion is accomplished [5]. Notably, the PARIHS framework
was included in the development of the CFIR.
We then followed a step-wise approach (Table 1) to
intervention design and development using the body of
work by Michie and colleagues [12-17] to organize and
conceptualize strategies to change behaviours. Given the
current scope and stage of our research program, key
behaviour changes were designed to occur at the level of
community pharmacists interacting with people with
lived experience of mental illness while still recognizing
the many factors (e.g., inner and outer setting, interven-
tion, etc.) that would influence the success or failures of
implementing an intervention. Using our iterative and
fluid process, we moved between the Behaviour Change
Wheel [12] with the stepwise process to intervention de-
velopment and the meta-view of implementation consid-
erations afforded by our discussions of the CFIR [5].
In the first step, the target behaviours of a typical
pharmacist in a community pharmacy setting, regardless
of pharmacy type (e.g., chain, independent, banner), wereTable 1 Steps for designing interventions to change commun
Steps
Step 1: Identify the target behaviours of pharmacists Answer the questio
Step 2: Understand the target behaviours of
pharmacists in community pharmacy contexts
Answer the questio
differently? Conduc
Step 3: Consider the full range of interventions functions Use the Behaviour
Step 4: Identify specific behaviour change techniques Use behaviour cha
knowledge to suppidentified. Engaging in these discussions allowed us to de-
tail why specific behaviours occur the way they do in prac-
tice and who needs to do what differently when, where,
and how. We characterized what would be considered
usual and customary pharmacist practices regarding inter-
actions with people with lived experience of mental illness.
We were informed by standards of professional practice of
the time, international literature regarding practices, and
more importantly, previous and ongoing contextually rele-
vant research in our province [18-20] and our tacit know-
ledge regarding expectations of pharmacists and patients
alike in typical encounters. At the time of intervention de-
velopment, interactions between pharmacists and patients
would most often occur at the time of dispensation of psy-
chotropics, and potentially other medications for physical
health problems. These discussions between pharmacists
and patients would commonly include information
regarding risks (e.g., undesirable effects) and benefits
(e.g., time to symptom improvement) of medications.
Our intention with developing an intervention was to
enhance the pharmacist’s role in mental health care in
a community pharmacy context, which would include
practicing differently towards more actively engagingity pharmacists’ behaviour in mental health care [12]
Activities
ns: Who needs to do what differently, when, where and how?
ns: Why do we do what we do? What needs to change to do things
t a COM-B assessment (Figure 2).
Change Wheel (Figure 3).
nge techniques based on published evidence, if available, and tacit
ort their use in changing the behaviours of pharmacists.
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related and non-medication-related responsibilities. Exam-
ples of the latter would include: giving navigation support
such as providing patients with information on local
community-based resources either within or outside of
the formal mental health system; providing educational
outreach sessions (e.g., medications for mental and phys-
ical health conditions) for families and patients depending
on needs; and overtly establishing partnerships with one
or more people with lived experience of mental illness
in communities to capitalize on their knowledge of
community resources and relationship capital within
communities.
As outlined in step 2 (Table 1), conducting the
COM-B (C - capability, O - opportunity, M - motivation,
and B – behaviour) (Figure 2) assessment, included de-
scribing the pharmacist’s capability (i.e., psychological
or physical ability to enact the behaviour), motivation
(i.e., reflective and automatic mechanisms that activate
or inhibit behaviour such as the beliefs, intentions, plans,
and wants and needs), and opportunity (i.e., physical and
social environment enabling the behaviour) for behaviour
change intervention design [12]. In order to complete the
COM-B assessment, we continued to rely on published lit-
erature, our previous [18,19] and ongoing research, some
of which included application of the Theoretical Domains
Framework, [20] and our considerable tacit knowledge of
community pharmacy practice and mental health. Based
on our cumulative knowledge and experience, we recog-
nized the importance of developing an intervention that
would target factors within all three components of the
COM-B assessment in order to support pharmacists’ be-
haviour change in mental health care. As described by
Michie et al., [12] and shown in the COM-B model of be-
haviour, each factor can influence one another such that
capability and opportunity can influence motivation. Sub-
sequently carrying out and engaging in behaviours canFigure 2 The COM-B system: a framework for understanding behaviofeedback to influence each of capability, opportunity, and
motivation [12]. For pharmacists to improve services for
people with lived experience of mental illness, our COM-
B assessment generated many questions. Examples per
component included:
Capability: Do pharmacists know how to appropriately
engage people with lived experience of mental illness?
Do they know how to manage and monitor patients’
pharmacotherapy and mental illness(es)?
Opportunity: Do pharmacists have access to resources
to support appropriate management of conditions? Is
the pharmacy equipped with a private room or area to
discuss mental health concerns? Is there a stigma-free
culture within the pharmacy team (e.g., pharmacists,
pharmacy technicians, assistants)?
Motivations: When and how do pharmacists plan to
provide services and follow-up care to people with lived
experience of mental illness? Do pharmacists believe
that providing improved services to people with lived
experience is a good thing? Do the pharmacists have
stigmatizing views? Do pharmacists want to provide
these services and why? What are the incentives and
disincentives to pharmacists providing improved services?
What habits do pharmacists have around the existing
service delivery for people with lived experience of
mental illness?
Following the COM-B assessment in step 3 (Table 1), we
considered a range of intervention functions (i.e., unique
aspects of activities intended to lead to behaviour change)
using the Behaviour Change Wheel for designing our inter-
vention (Figure 3) [12]. This approach has been used and
further adapted by others [21]. Michie and colleagues spe-
cifically demonstrate linkages with the COM-B model of
behaviour and intervention functions [12]. We applied this
in our process to determine suitable intervention functionsur [12].
Figure 3 The Behaviour Change Wheel [12].
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ercise within our research team. This included examining
literature (published and grey) for effectiveness of sug-
gested intervention functions and considerations of feasi-
bility, efficiencies, and costs.
To demonstrate using one component of the COM-B
assessment, capability, we discussed that pharmacists
frequently report perceived deficits in knowledge and
skills about how to best engage with people with lived
experience of mental illness, not only with verbal com-
munications but body language within physical spaces
such as private counseling areas. In essence, the con-
cerns reflected both physical and psychological capability
of the pharmacists and based on the work of Michie
et al., [12] education and training are intervention func-
tions linked with capability. Generally, education and
training sessions are standard approaches that are widely
accepted by pharmacists for continuing professional
education and development, including for purposes of
professional licensure maintenance.
We then moved to step 4 to identify specific behaviour
change techniques. We reviewed the 40 behaviour change
techniques developed by Michie et al. [15,17] and selected
those deemed feasible, affordable, practical, and suitable
to fit within our determined intervention functions. The
expanded list of 93 behaviour change techniques was pub-
lished after our intervention was designed [13] but can be
considered for future interventions. Potential behaviour
change techniques were also prioritized based on our
knowledge and information from sources including pub-
lished and grey literature [22].
Our program’s implementation subsequently moved for-
ward with intervention implementation planning and exe-
cution by revisiting our discussions based on the CFIR.
Examples of the integration with concepts exploredthrough the CFIR and the intervention development and
implementation are further discussed in the results.
Results
Moving between applying the CFIR [5] and the Behaviour
Change Wheel [12] to the development and implementa-
tion of a capacity-building, community pharmacy mental
health care program (Table 2) enabled the research team
to conceptualize factors and variables that could actually
or potentially enable or challenge the development and
implementation of the program.
Many factors were considered and yet not all, espe-
cially macro considerations from the outer setting, were
amenable to change within the scope of our interven-
tion, such as political and economic influences. These
factors were considered in the intervention design by ad-
dressing how pharmacists could respond in practice to
these external or outer setting influences as identified in
discussing the CFIR. For example, after conducting the
COM-B assessment (Table 3), opportunity can influence
the behaviour of pharmacists. This can manifest in the
inner setting or community pharmacy practice environ-
ment as a perceived lack of time or human resources,
and for some pharmacies, a lack of private space for dis-
cussions, which would require funding and renovations.
These barriers to implementing new interventions in the
inner setting can originate from numerous variables in
the outer setting given these contexts are so closely linked
as per the CFIR [5]. These factors can include, but are not
limited to, economic influences such as those related to
reimbursement of pharmacies for dispensing fees through
private and public plans, changes in rules regarding medi-
cation manufacturer rebates, and other modifications in
pharmacy business models that create change in the com-
munity pharmacy work environment. To overcome some
Table 2 Application of the Consolidated Framework for Implementation Research (CFIR) to enhancing mental health
care in pharmacy practice
Domain of CFIR Example considerations for community pharmacy mental health care
Outer setting Economic factors and funding model for service, belief in whether pharmacists are capable of service provision,
competition and business interests within pharmacy community, general availability of mental health services.
Inner setting Pharmacy type (e.g., chain, franchise, banner, independent, mass merchandisers & food stores), location (e.g., rural,
urban), culture, computer systems, dispensary, private patient room/space, proximity and relationships with local
prescribers and mental health care professionals.
Individuals involved Community pharmacists, pharmacy technicians and assistants, front store staff, people with lived experience of mental
illness and/or their support people.
Intervention “Buy-in” from pharmacists, complexity of intervention, trialability, adaptability, relative advantage, evidence behind the
intervention, quality and packaging of intervention, costs, core components such as: use of website; tools for facilitating
health system navigation for patients; and community of practice communications. Adaptable periphery would include
when and how to use the tools.
Intervention implementation
process
Sub-processes that focus on the elements of the inner setting, individuals, adaptable intervention, and discussion
regarding outer setting complexity and impact on intervention.
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through examining the CFIR, the development of the
intervention included discussions and examples in the
education and training and throughout the program, of
how to create environmental restructuring (i.e., change to
the social or physical context) such as restructuring phar-
macy technician and pharmacist workflow to allow for the
intervention implementation, and enablement (i.e., increas-
ing means and/or reducing barriers to increase opportunity
or capability) [12] such as capitalizing on relationships with
people with lived experience of mental illness in communi-
ties to facilitate determining appropriate resources that
pharmacists can direct patients to accessing. Specific be-
haviour change techniques that were included during these
exercises included: providing information on others’
approval of the behaviour; goal setting (behaviour and
outcome); action planning; barrier identification/prob-
lem solving; setting graded tasks; providing instruction
on when, where and how to perform the behaviour;Table 3 Capability, opportunity, motivation-behaviour (COM-
care
COM-B assessment Examples for community pharmacy-bas
Capability
• Psychological and physical
ability
Pharmacists can improve knowledge regar
illnesses.
Motivation
• Reflective Pharmacists do not always recognize that p
level of service, or at times, require a highe
• Automatic
Most pharmacists intend to provide service
Pharmacist do not always plan to offer add
Opportunity
• Physical and social
environment
Stigma is still a factor in community pharm
illness.
Barriers such as limited time, resources (inc
discussion) are prevalent.environmental restructuring; and modeling and dem-
onstrating the behaviour [15].
From the COM-B assessment exercise, we outlined rele-
vant factors from published literature and our tacit know-
ledge regarding pharmacy practice and mental health care.
Table 3 provides our examples of these factors related to
our study.
The potential intervention functions identified and pri-
oritized based on our knowledge and information from
various resources are shown in Table 4.
The behaviour change techniques [13,15,17] primarily
employed throughout our capacity building program are
displayed in Table 5.
This process in its entirety led us to the development
of More Than Meds. Briefly, More Than Meds is a
capacity-building project to support pharmacists in pro-
viding enhanced mental health care for people with lived
experience of mental illness. More Than Meds included
multiple components: an education and training day thatB) assessment of community pharmacists in mental health
ed mental health care
ding current therapeutics and condition-specific knowledge for mental
eople with lived experience of mental illness are not receiving the same
r level of service in keeping with the principle of vertical equity.
s in keeping with standards of practice.
itional services to people with lived experience of mental illness.
acy setting within pharmacy staff that impacts care of those with mental
luding staff), and physical space limitations (e.g., lack of private area for




Potential model of behaviour
addressed [12,14]
Examples of current and potential strategies related to community-pharmacy
based mental health care
Education Psychological ability – capability Education and training day on mental health including wellness and illness.
Reflective – motivation
Training Psychological ability – capability Interaction during education and training day facilitated by experts with case-based
learning and simulated patients focusing on communication and management
approaches for mental illness.Physical ability – capability
Persuasion Reflective – motivation Sending pharmacists literature with statistics regarding prevalence of conditions,
various services that provide benefits, and outcomes achieved with pharmacist
interventions.Automatic – motivation
Use of people with lived experience of mental illness as partners in the project.
Sending group emails with congratulatory messages to any pharmacists who
did educational outreach sessions.
Incentivisation Reflective – motivation Using pay for performance incentives for training other pharmacists regarding
the program and tools.
Automatic – motivation
Community of practice inclusive of resource sharing (e.g., websites) created with
group of pharmacists.
Recognition of successes and activities through community of practice email.
Coercion Reflective motivation Retraction or withholding of money for lack of training of other pharmacists.
Automatic motivation
Restriction Physical environment -
opportunity
Rules and restriction on the kinds of services and interventions eligible for
pharmacists to perform in the program.
Social environment – opportunity
Environmental
restructuring
Automatic – motivation Using posters in the pharmacies to advertise mental health-related services.
Physical environment – opportunity Using education and training regarding principles of the program to encourage
and promote a stigma-free pharmacy culture.
Social environment – opportunity
Use prompts or cues with the help of computerized systems to guide pharmacists
in patient monitoring (e.g., run report of all patients taking antipsychotics and use
manual or computerized prompt for pharmacists to ask patients regarding blood
work or smoking status).
Modeling Automatic – motivation Using video clips or simulated patients demonstrating pharmacists’ assessments and
monitoring of patients with mental illnesses.
Psychological ability – capability
Enablement Psychological ability – capability Providing pharmacists with access to community supports through knowledgeable
people with lived experience in communities and establishing linkages in a
community of practice for advice and guidance on patient-related questions.
Physical ability – capability Booking appointments in the pharmacies for pharmacists to spend more time
with people with lived experience of mental illness.
Physical environment – opportunity
Social environment – opportunity
Automatic – motivation
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munity members with lived experience of mental illness
(n = 6) and eventually, 35 trained pharmacists; establish-
ment of a community of practice via a website, regular
communications, a newsletter, and the use of social media;
train-the-trainer model with payments to pharmacists and
community members for jointly training five other
pharmacists in local or neighbouring communities;
and pharmacist-led delivery of educational outreach to
people with lived experience of mental illness in their
communities. We collected pre and post knowledgeand attitudes questionnaires; satisfaction surveys com-
pleted by pharmacists and community members who
participated in the education and training components;
feedback from participants attending the pharmacist-
led educational outreach sessions; data regarding simu-
lated patient consultation to community pharmacists
who participated and who did not participate in the
program; and qualitative interviews with an interview
guide developed based on the Theoretical Domains
Framework [14]. Results will be reported once the ana-
lyses are complete.
Table 5 Behaviour change technique [15] examples to address behaviour change in community pharmacists’ provision
of mental health services
Behaviour change technique [15] Examples of strategies used
Provide information about others’ approval Use contact-based education with people with lived experience of mental illnesses to discuss what
experiences have been positive and negative related to pharmacy practice.
Provide normative information about others’
behaviours
Discuss best practice and what pharmacists are doing for gold-standard care in mental health.
Facilitate social comparisons Drawing attention to one or more pharmacists’ behaviours and performance in doing educational
outreach.
Goal setting (behaviour) Encourage pharmacists to make resolutions such as increasing monitoring and follow-up of patients
receiving medications for mental illnesses.
Set graded tasks Prior to delivering an educational intervention in the community, plan to perform tasks in sequence
such as meet ahead of time with a community member to plan the event and organize resources
prior to the event.
Action planning Help pharmacists to develop SMART (specific, measurable, achievable, relevant, time-bound) goals
around how often and when to screen for sleep problems, to use health system navigation support
tools, and to work with community organizations to schedule education sessions.
Provide instruction on how to perform the
behaviour
Tell and show pharmacists how to use health system navigation support tools.
Model/demonstrate the behaviour Physically demonstrate through a case-based or simulated patient exercise the techniques for
interviewing, assessing, and monitoring a patient with a mental health concern.
Provide information on where and when to
perform the behaviour
Tell pharmacists about when and where to engage in related More Than Meds activities in their
pharmacy.
Provide information on how to perform the
behaviour
Discuss and use simulated patients to tell pharmacists how to perform the behaviours. Use
computerized reminders on patient files to remind pharmacists about the program.
Teach to use prompts/cues Use More Than Meds marketing and advertising materials in the pharmacy as a reminder to engage
in the behaviours.
Use of follow-up prompts Group emails to pharmacists reminding them of program principles, activities, and requirements.
Environmental restructuring Alter aspects of the pharmacy to be able to accommodate More Than Meds materials in patient
waiting area and in dispensary resource and how to better meet needs of patients with lived
experience of mental illness in private counseling areas.
Time management Discuss as a group how to manage time within workflow demands.
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To our knowledge, this is the first community
pharmacy-based intervention whose development and
implementation was underpinned primarily by the CFIR
and the work of Michie et al., including the Behaviour
Change Wheel. In our experiences, the theoretical foun-
dations of intervention development and implementa-
tion in pharmacy practice research literature is often
limited or not described. There is a significant volume
of research that reports on retrospective examinations
of barriers and facilitators to intervention implementa-
tion in a practice change but theoretical forethought is
less common, or if it exists, it is not discussed. These is-
sues have been described by others such as Norgaard
et al. [23] who encouraged debate around much of phar-
macy practice research that focuses on describing the
“what” and the “how many” as compared to the “why?”
and “for whom?”. A recent systematic review that aimed
to identify studies reporting data on pharmacists’ behav-
iours in clinical service provision included 21 trials of
which five studies included a theoretical framework
[24]. This review focused on empirical interventionstudies and, as such, did not include research using other in-
formative methods including qualitative inquiry such as
those by Roberts et al. [25] or Makowsky et al. [26] or other
non-quantitative study [27] and review methods [28]. These
additional studies contribute knowledge in advancing the
science of pharmacy practice towards inclusion of a theoret-
ical foundation. The increased interest in a theoretical
approach to explaining behaviours of pharmacists may,
in part, be attributable to expanding scopes of practice
including the advent of pharmaceutical care in the late
1990s. Arguably, if the pharmacy profession is to con-
tinue to move forward with expanding scopes, a theoret-
ical basis to research will be required to advance an
understanding of not only why services succeed or fail
but also how to appropriately design services and imple-
ment them in community pharmacy contexts. More
study will also be required to develop mechanisms for
assessing context in community pharmacy practice and
the work of other scholars in this area can be tested and
adapted [29,30]. It will also be important for pharmacy
practice researchers to remain engaged with literature
and emerging theory on intervention evolution during
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the implementation of More Than Meds, sustainability
of interventions was described by Chambers et al., [31]
and includes the process of managing and supporting
the intervention evolution within a changing context.
This model of intervention implementation called the Dy-
namic Sustainability Framework [31] aligns with our overall
approach to the mechanics of implementation with More
Than Meds in which we attempted to maximize the fit of
More Than Meds between practice settings and the broader
ecological system through: continued learning and problem
solving within our community of practice; ongoing adapta-
tion of core components of More Than Meds in that we
gave pharmacists freedoms and flexibilities to make needed
changes in their context and considering fit with multi-
level contexts; and ongoing improvements based on feed-
back to the research team and shared with the community
of practice. An area in which we will require further devel-
opment and study in our own program of research, as with
much of existing pharmacy practice research, will be devel-
oping mechanisms for determining the degree of core
intervention component adaptation and manipulation that
can produce a desired range of effectiveness upon
replication.
Conclusion
Theory was essential to the underlying development and
implementation of a capacity-building program for en-
hancing services by pharmacists for people with lived ex-
perience of mental illness. Lessons learned from the
development and implementation of this program are
informing ongoing research and the next phase of the
program (http://bloomprogram.ca). As pharmacy prac-
tice advances forward with expanding scopes and in-
creasing responsibilities in patient care activities, a
theoretical foundation to developing, implementing, and
evaluating services in changing contexts is necessary.
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